OLN.NYSEOlin CORP

Form 4: Olin VP & Treasurer Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


Olin Corporation's VP & Treasurer, Teresa M. Vermillion, exercised stock options and subsequently sold an equal number of shares under a pre-arranged 10b5-1 plan.

Summary

  • Teresa M. Vermillion, VP & Treasurer of Olin Corporation, engaged in transactions involving Olin Common Stock on November 26, 2025.
  • She acquired 4,500 shares of Common Stock by exercising employee stock options at a price of $13.14 per share.
  • Concurrently, she disposed of 4,500 shares of Common Stock at a weighted average price of $20.8556 per share, with individual sales ranging from $20.83 to $20.87.
  • These transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.
  • Following these transactions, her direct beneficial ownership stands at 17,199 shares, and indirect ownership through the Olin Corporation Retirement Savings Plan is 140.7607 shares.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While an insider sale can be seen negatively, the context of option exercise and a 10b5-1 plan makes it a routine, expected event for executive compensation management. The profit realized by the insider is a positive for the individual.

Positives

  • The exercise of options and subsequent sale indicates a profit for the insider, as the sale price ($20.8556) was significantly higher than the exercise price ($13.14).
  • The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned and orderly disposition of shares, which can reduce concerns about opportunistic trading.

Negatives

  • An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake in the company.

Industry Context

This Form 4 filing details routine insider transactions for a senior executive at Olin Corporation, a major player in the chemical industry. Such transactions are common for executives managing their equity compensation and personal financial planning, often through pre-arranged 10b5-1 plans.

Comparison to Industry Standards

  • Insider transactions like these are standard practice across all industries, including chemicals. The use of a Rule 10b5-1 plan aligns with best practices for corporate governance, providing a structured approach for insiders to trade company stock without concerns of using material non-public information.
  • For example, executives at companies like Dow Inc. or LyondellBasell Industries N.V. frequently utilize similar plans for managing their equity compensation.

Stakeholder Impact

  • Shareholders: The sale by a VP & Treasurer might be viewed with slight caution, but the 10b5-1 plan mitigates concerns. The overall impact on the company's operations or strategic direction is negligible.
  • Employees: No direct impact.
  • Customers/Suppliers/Creditors: No direct impact.

Key Dates

DateDescription
02/12/2017Employee Stock Options became exercisable.
11/26/2025Date of earliest transaction (exercise of options and sale of shares).
11/26/2025Date as of which RSP Plan Administrator reported indirect share holdings.
11/28/2025Signature date of the reporting person's attorney-in-fact.
02/11/2026Expiration date of the Employee Stock Options.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. Such transactions are common for executives managing their compensation and personal finances and do not typically signal a change in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation for Olin Corporation based solely on this filing.

Keywords

Olin Corporation, OLN, Insider Trading, Form 4, Stock Options, Share Sale, Teresa M. Vermillion, 10b5-1 Plan, Corporate Officer, Chemicals Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.